SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Protagenic Therapeutics, Inc. Merger

Wilmington, Delaware--(Newsfile Corp. - May 20, 2025) - Rigrodsky Law, P.A. is investigating Protagenic Therapeutics, Inc. ("Protagenic") (NASDAQ: PTIX) regarding possible breaches of fiduciary duties and other violations of law related to Protagenic's agreement to merge with Phytanix Bio Inc.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-protagenic-therapeutics-inc.

To contact Seth D. Rigrodsky or Gina M. Serra cost free, call [phone] or email [e-mail].

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

Contact:
Rigrodsky Law, P.A.
Seth D. Rigrodsky, Esq.
Gina M. Serra, Esq.
Telephone: [phone]
Email: [e-mail]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/252751

The Protagenic Therapeutics Stock at the time of publication of the news with a raise of +2,09 % to 0,244USD on Lang & Schwarz stock exchange (17. März 2025, 20:58 Uhr).